Resmed Inc (NYSE: RMD)

ResMed Inc is a global leader in digital health and cloud-connected medical devices that designs innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. The company focuses on sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases, providing comprehensive residential care software platforms that support professionals and caregivers helping people stay healthy in the home or care setting of their choice.

ResMed Inc generates revenue through the sale of devices such as CPAP, APAP, bilevel, adaptive servo-ventilation, and high flow therapy systems, along with mask systems, diagnostic products, headgear, accessories, and dental devices. The company also earns revenue from cloud-based health applications, software, and devices that enable connected care, including patient engagement applications like myAir and remote monitoring platforms like AirView. Residential Care Software solutions contribute additional revenue by providing business management, electronic health records, revenue cycle management, and workforce management tools to healthcare providers in residential care settings.

ResMed Inc operates through the following segments: Sleep and Breathing Health segment and Residential Care Software segment.

• The Sleep and Breathing Health segment develops and commercializes continuous positive airway pressure treatment for obstructive sleep apnea, along with innovative products for respiratory disorders including ventilation devices, diagnostic products, mask systems for hospital and home use, headgear and accessories, and dental devices. This segment also provides cloud-based health applications and software designed to provide connected care, enabling clinicians to manage patients efficiently and encouraging long-term patient adherence to therapy.

• The Residential Care Software segment provides cloud-based solutions to healthcare providers operating in the residential care market, including home medical equipment and home infusion providers, home health and hospice agencies, skilled nursing facilities, private duty nursing organizations, senior living facilities, and life plan communities. These solutions support analytics, documentation management, reimbursement compliance, and data transfer as patients move between care settings, with capabilities for billing, business management, electronic medical records, revenue cycle management, operational analytics, patient engagement, and workforce management.

ResMed Inc holds a leading position in the sleep and breathing health market, competing with companies such as Philips BV, Fisher & Paykel Healthcare Corporation Limited, DeVilbiss Healthcare, Apex Medical Corporation, BMC Medical Co Ltd, React Health Corporation, Jiangsu Yuyue Medical Equipment & Supply Co Ltd, and Lowenstein Medical SE & Co KG. The company's competitive advantages stem from its focus on smaller, quieter, more comfortable, and more connected products, integration of artificial intelligence and machine learning algorithms to enhance therapy performance, and its extensive installed base of over 30 million patients using cloud-connected devices on AirView and over 10 million patients registered to the myAir platform.

ResMed Inc serves a diverse customer base including home medical equipment providers, health systems, sleep clinics, hospitals, durable medical equipment suppliers, home health and hospice agencies, skilled nursing facilities, senior living organizations, life plan communities, and individual patients diagnosed with sleep apnea, COPD, and other respiratory conditions. The company also works with prescribing practitioners, insurers, and durable medical equipment providers who assist patients in selecting and using its products.